Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease ; volume:12 ; number:1 ; day:29 ; month:4 ; year:2021 ; pages:1-12 ; date:12.2021
Stem cell research & therapy ; 12, Heft 1 (29.4.2021), 1-12, 12.2021
- Urheber
-
Coccia, Elena
Ahfeldt, Tim
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-021-02326-5
- URN
-
urn:nbn:de:101:1-2021061620551669335797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Coccia, Elena
- Ahfeldt, Tim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Development of Physiologically Relevant Skin Organoids from Human Induced Pluripotent Stem Cells
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
Endosomal dysfunction in iPSC-derived neural cells from Parkinson’s disease patients with VPS35 D620N
Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization
Optical genome mapping of structural variants in Parkinson’s disease-related induced pluripotent stem cells
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Establishment and characterization of human Engrailed1 knockout iPSC models in the context of Parkinson’s Disease pathophysiology.
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
Parkinson
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Development of Physiologically Relevant Skin Organoids from Human Induced Pluripotent Stem Cells
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
Endosomal dysfunction in iPSC-derived neural cells from Parkinson’s disease patients with VPS35 D620N
Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization
Optical genome mapping of structural variants in Parkinson’s disease-related induced pluripotent stem cells
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Establishment and characterization of human Engrailed1 knockout iPSC models in the context of Parkinson’s Disease pathophysiology.
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
Parkinson
Patient-Specific Induced Pluripotent Stem Cell Models of Parkinson’s Disease
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Development of Physiologically Relevant Skin Organoids from Human Induced Pluripotent Stem Cells
Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
Endosomal dysfunction in iPSC-derived neural cells from Parkinson’s disease patients with VPS35 D620N
Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization
Optical genome mapping of structural variants in Parkinson’s disease-related induced pluripotent stem cells
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Establishment and characterization of human Engrailed1 knockout iPSC models in the context of Parkinson’s Disease pathophysiology.
Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol